C60 Fullerene and COX-2 Inhibitor Nutraceutical Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nutraceutical formulations using fullerene derivatives do not effectively address both inflammation and oxidative stress simultaneously.
Innovation Solution
A combination of C60 fullerene, a COX-2 inhibitor, and medium chain triglycerides, preferably with an emulsifier, is used to create an anti-inflammatory and anti-oxidative nutraceutical composition that acts as a carrier for both components, enhancing health benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If C60 fullerene is used as an antioxidant, then oxidative stress is reduced, but inflammation is not effectively addressed
Solution Approach 1:
The patent combines C60 fullerene (antioxidant) with COX-2 inhibitor (anti-inflammatory) in a single nutraceutical composition, merging two distinct therapeutic functions into one product. This resolves the contradiction by simultaneously providing both oxidative stress reduction and inflammation control that neither component could achieve alone.
Solution Approach 2:
The invention creates a composite nutraceutical formulation containing multiple active ingredients (C60 fullerene, COX-2 inhibitor, and medium chain triglyceride carrier) that work synergistically. This composite approach allows the composition to address both oxidative stress and inflammation, overcoming the limitation of single-component formulations.
2Object-affected harmful factors
If COX-2 inhibitor is used to reduce inflammation, then prostaglandin production is reduced, but oxidative stress is not effectively addressed
Solution Approach 1:
The patent combines C60 fullerene (antioxidant) with COX-2 inhibitor (anti-inflammatory) in a single nutraceutical composition, merging two distinct therapeutic functions into one product. This resolves the contradiction by simultaneously providing both oxidative stress reduction and inflammation control that neither component could achieve alone.
Solution Approach 2:
The invention creates a composite nutraceutical formulation containing multiple active ingredients (C60 fullerene, COX-2 inhibitor, and medium chain triglyceride carrier) that work synergistically. This composite approach allows the composition to address both oxidative stress and inflammation, overcoming the limitation of single-component formulations.
3Reliability
If C60 is dissolved in lipid carrier, then bioavailability is improved, but the formulation does not provide anti-inflammatory benefits
Solution Approach 1:
The patent combines C60 fullerene (antioxidant) with COX-2 inhibitor (anti-inflammatory) in a single nutraceutical composition, merging two distinct therapeutic functions into one product. This resolves the contradiction by simultaneously providing both oxidative stress reduction and inflammation control that neither component could achieve alone.
Solution Approach 2:
The invention creates a composite nutraceutical formulation containing multiple active ingredients (C60 fullerene, COX-2 inhibitor, and medium chain triglyceride carrier) that work synergistically. This composite approach allows the composition to address both oxidative stress and inflammation, overcoming the limitation of single-component formulations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition demonstrates synergistic effects in reducing oxidative stress, inflammation, and promoting health benefits such as longevity, anti-aging, and preventing various diseases, with anecdotal evidence showing effectiveness in human volunteers.
Implementation Method 1
Due to its 30 carbon double bonds, 60-carbon fullerene is a powerful and recyclable antioxidant that neutralizes harmful free radicals. It is reported to be 172 times more potent than Vitamin C, working as an electron reservoir to defuse reactive oxygen species (ROS) in the body
Implementation Method 2
C60 has an apparent ability to acquire positive charge by absorbing several protons, and this complex can then penetrate into mitochondria. Such a process allows for mild uncoupling of respiration and phosphorylation, which in turn leads to decrease in ROS production
Implementation Method 3
Cyclooxygenase-2 (i.e., COX-2), is an enzyme that is involved in the conversion of arachidonic acid (AA) to prostaglandin. Prostaglandin levels are increased by COX-2 during inflammation and growth, and COX-2 inhibitors can reduce the production of prostaglandins that promote inflammation
Data Source
AI summary
An anti-inflammatory and anti-oxidative nutraceutical composition containing C60 fullerene, a COX-2 inhibitor, and a medium chain triglyceride. The combined use of C60 and COX-2 inhibitor has unexpected benefits in promoting health, including synergistic effects in fighting cancer, slowing aging, and in some cases, reversing aging. Advantageously, Nigella sativa (“black seed”) oil is used to provide both medium chain triglycerides and COX-2 inhibitors.